Study of LM-302 in Patients With Advance Solid Tumors

Clinical trial NCT05161390 · COMPLETED

Trial details

NCT number: NCT05161390
Sponsor: LaNova Medicines Zhejiang Co., Ltd.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2021-11-26
Primary completion: 2025-01-10
Enrollment: 153

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.